Women with a previous BC history should be considered as an important particular subset of women with an intermediate BC risk, lower than that of BRCA or p53 mutation carriers and higher than that of women with neither personal nor familial BC history, or with only sporadic BCs among their relatives [11]. The gene discussed is TP53; the disease is breast cancer.